Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.64 |
| ▸ | FAAH | O00519 | 4/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | SELP | P16109 | 1/20 | 0.46 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.45 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.45 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.45 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.45 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.45 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.45 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.45 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.45 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.45 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2119141 | 0.89 | DGKA (0.67) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL4640603 | 0.89 | DGKA (0.67) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL8332208 | 0.89 | DGKA (0.67) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL2118873 | 0.89 | DGKA (0.67) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL8636691 | 0.89 | DGKA (0.67) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL9173378 | 0.87 | KDM4E (0.63) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL252664 | 0.87 | KDM4E (0.63) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL21617316 | 0.87 | KDM4E (0.63) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL21419884 | 0.87 | KDM4E (0.63) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL14778640 | 0.87 | KDM4E (0.63) | DGKAFAAHKDM4EDUSP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9314021-B2 | Formulations containing insect repellent compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2016-04-19 | — | — | US | disclosed |
| WO-2016020936-A2 | A NOVEL ORAL GASTRORETENTIVE PHARMACEUTICAL DOSAGE FORM | PATEL JAYENDRAKUMAR DASHARATHLAL (IN) | 2016-02-11 | — | — | WO | disclosed |
| US-20140288167-A1 | Formulations Containing Insect Repellent Compounds | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-09-25 | — | — | US | disclosed |
| US-8771718-B2 | Formulated tick and insect repellent compositions | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-07-08 | — | — | US | disclosed |
| US-8748477-B2 | Formulations containing insect repellent compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-06-10 | — | — | US | disclosed |
| EP-2040555-A2 | FORMULATED TICK AND INSECT REPELLENT COMPOSITIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-04-01 | — | — | EP | disclosed |
| WO-2007133683-A2 | FORMULATED TICK AND INSECT REPELLENT COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-11-22 | — | — | WO | disclosed |
| US-20070264297-A1 | Formulated tick and insect repellent compositions | 1,4Group, Inc. | 2007-11-15 | — | — | US | disclosed |
| EP-1806969-A1 | INSECT REPELLENT COMPOSITIONS COMPRISING DIHYDRONEPETALACTONE, AN ALCOHOL, AND AN ESTER | E.I.Du pont de nemours and company (US) | 2007-07-18 | — | — | EP | disclosed |
| US-20060223878-A1 | Formulations containing insect repellent compounds | 1,4Group, Inc. | 2006-10-05 | — | — | US | disclosed |
| WO-2006050519-A1 | INSECT REPELLENT COMPOSITIONS COMPRISING DIHYDRONEPETALACTONE, AN ALCOHOL, AND AN ESTER | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140288167-A1 | Formulations Containing Insect Repellent Compounds | CAT, HNMT, MME | DGKA 2547/4885FAAH 360/4885KDM4E 2662/4885 |
| US-20060223878-A1 | Formulations containing insect repellent compounds | CAT, HNMT, MME | DGKA 2547/4885FAAH 360/4885KDM4E 2662/4885 |
| US-20070264297-A1 | Formulated tick and insect repellent compositions | MME, FNTA, ACHE | DGKA 2256/4885FAAH 172/4885KDM4E 1284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.